Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Agilent Technologies (NY: A )

154.51 +2.27 (+1.49%)
Official Closing Price Updated: 7:00 PM EST, Feb 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,126,669
Open 151.49
Bid (Size) 152.36 (1)
Ask (Size) 156.07 (1)
Prev. Close 152.24
Today's Range 151.13 - 154.96
52wk Range 112.52 - 160.26
Shares Outstanding 303,443,225
Dividend Yield 0.50%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
The 7 Best Manufacturing Stocks to Buy for 2023
These manufacturing stocks to buy provide a great alternative to tech stocks that have been so badly beaten in recent weeks. 
Via InvestorPlace
Agilent to Announce First-Quarter Fiscal Year 2023 Financial Results Feb. 28
From Agilent Technologies Inc.
Via Business Wire

Performance

YTD
+2.98%
+2.98%
1 Month
+4.77%
+4.77%
3 Month
+11.36%
+11.36%
6 Month
+19.89%
+19.89%
1 Year
+10.07%
+10.07%

More News

Read More
Here's How Much $1000 Invested In Agilent Technologies 15 Years Ago Would Be Worth Today
Via Benzinga
Agilent to Collaborate with Quest Diagnostics to Extend Access to the Agilent Resolution ctDx FIRST Liquid Biopsy Test
From Agilent Technologies Inc.
Via Business Wire
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
Via Benzinga
Analyst Ratings for Agilent Technologies
Via Benzinga
4 Analysts Have This to Say About Agilent Technologies
Via Benzinga
Agilent Included in Just Capital’s 2023 List of Most Just Companies
From Agilent Technologies Inc.
Via Business Wire
Agilent Authorizes $2 Billion Share Repurchase Program
From Agilent Technologies Inc.
Via Business Wire
Agilent Investing $725 Million to Expand State-of-the-Art Manufacturing Capacity for Production of Nucleic Acid-Based Therapeutics
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
From Agilent Technologies Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2023
Via Benzinga
Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications
From Agilent Technologies Inc.
Via Business Wire
Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences
From Agilent Technologies Inc.
Via Business Wire
Ukraine's Zelenskyy Slams Olympics' 'Neutral Flag' Idea For Putin's Athletes: 'All Their Flags Are Stained With Blood'
Via Benzinga
Agilent Resolution ctDx FIRST Receives FDA Approval as a Liquid Biopsy Companion Diagnostic Test for Advanced Non-small Cell Lung Cancer
From Agilent Technologies Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
DoorDash, Southern Company And These 2 Other Stocks Insiders Are Selling
Via Benzinga
The Little-Known Tech Company Making A Big Splash
Via Talk Markets
Agilent Again Named to Newsweek’s List of America’s Most Responsible Companies
From Agilent Technologies Inc.
Via Business Wire
Agilent Opens Customer Experience Center Highlighting Genomics and Diagnostics Solutions
From Agilent Technologies Inc.
Via Business Wire
Veracyte Stock Showing Market Leadership; Earns 93 RS Rating
Via Investor's Business Daily
Agilent Attains ‘Angel’ Level Sponsorship with My Green Lab
From Agilent Technologies Inc.
Via Business Wire
Agilent Deploys Next Generation Explosive Detection System at London Heathrow Airport
From Agilent Technologies Inc.
Via Business Wire
How Is The Market Feeling About Agilent Technologies?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.